...
首页> 外文期刊>The Journal of biological chemistry >The Chinese Herb Isolate Isorhapontigenin Induces Apoptosis in Human Cancer Cells by Down-regulating Overexpression of Antiapoptotic Protein XIAP
【24h】

The Chinese Herb Isolate Isorhapontigenin Induces Apoptosis in Human Cancer Cells by Down-regulating Overexpression of Antiapoptotic Protein XIAP

机译:中草药孤立的isorhapontigenin通过抑制抗曝气蛋白xiap的过表达诱导人癌细胞的细胞凋亡

获取原文
           

摘要

Although the Chinese herb Gnetum cleistostachyum has been used as a remedy for cancers for hundred years, the active compounds and molecular mechanisms underlying its anti-cancer activity have not been explored. Recently a new derivative of stilbene compound, isorhapontigenin (ISO), was isolated from this Chinese herb. In the present study, we examined the potential of ISO in anti-cancer activity and the mechanisms involved in human cancer cell lines. We found that ISO exhibited significant inhibitory effects on human bladder cancer cell growth that was accompanied by marked apoptotic induction as well as down-regulation of the X-linked inhibitor of apoptosis protein (XIAP). Further studies have shown that ISO down-regulation of XIAP protein expression was only observed in endogenous XIAP, but not in constitutionally exogenously expressed XIAP in the same cells, excluding the possibility of ISO regulating XIAP expression at the level of protein degradation. We also identified that ISO down-regulated XIAP gene transcription via inhibition of Sp1 transactivation. There was no significant effect of ISO on apoptosis and colony formation of cells transfected with exogenous HA-tagged XIAP. Collectively, current studies, for the first time to the best of our knowledge, identify ISO as a major active compound for the anti-cancer activity of G. cleistostachyum by down-regulation of XIAP expression and induction of apoptosis through specific targeting of a SP1 pathway, and cast new light on the treatment of the cancer patients with XIAP overexpression.
机译:虽然中草药Gnetum Cleistachyum已被用作癌症的补救措施,但尚未探讨其抗癌活动的活性化合物和分子机制。最近,斯蒂替斯化合物的新衍生物,Isorhapontigenin(ISO),从这个中草药中分离出来。在本研究中,我们检查了ISO在抗癌活动中的潜力和涉及人类癌细胞系中的机制。我们发现ISO对人膀胱癌细胞生长表现出显着的抑制作用,所述人膀胱癌细胞生长伴随着标记的凋亡诱导以及凋亡蛋白(XIAP)的X键抑制剂的下调。进一步的研究表明,XIAP蛋白表达的ISO下调仅在内源性XIAP中观察到,但在同一细胞中没有在致法外源表达的XIAP中,不包括ISO调节蛋白质降解水平的ISO调节XIAP表达的可能性。我们还通过抑制SP1转移来鉴定ISO下调的XIAP基因转录。 ISO对用外源HA标记的XIAP转染细胞的细胞凋亡和菌落形成没有显着影响。统称,目前的研究是我们的知识首次,通过XIAP表达和通过SP1的特异性靶向来确定XIAP表达和诱导细胞凋亡的抗癌活性的ISO作为G. Cleistostachyum的主要活性化合物。途径,对癌症过表达癌症患者的治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号